Business Description
SciSparc Ltd
ISIN : IL0010951403
Total Employee Number:
3Description
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 12.54 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -20.19 | |||||
Beneish M-Score | -5.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -82.8 | |||||
3-Year EBITDA Growth Rate | 65.2 | |||||
3-Year FCF Growth Rate | 86.2 | |||||
3-Year Book Growth Rate | -87.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 26.11 | |||||
9-Day RSI | 30.38 | |||||
14-Day RSI | 36.15 | |||||
3-1 Month Momentum % | 178.96 | |||||
6-1 Month Momentum % | -22.45 | |||||
12-1 Month Momentum % | -86.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.41 | |||||
Quick Ratio | 2.38 | |||||
Cash Ratio | 2.04 | |||||
Days Inventory | 184.93 | |||||
Days Sales Outstanding | 4.83 | |||||
Days Payable | 1301.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -614.7 | |||||
Shareholder Yield % | -158.61 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.72 | |||||
Operating Margin % | -1022.08 | |||||
Net Margin % | -1422.78 | |||||
EBITDA Margin % | -1439.14 | |||||
FCF Margin % | -483.29 | |||||
OCF Margin % | -483.29 | |||||
ROE % | -314.68 | |||||
ROA % | -158.11 | |||||
ROIC % | -155.53 | |||||
3-Year ROIIC % | 7.87 | |||||
ROC (Joel Greenblatt) % | -31646.22 | |||||
ROCE % | -261.19 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.51 | |||||
PB Ratio | 0.39 | |||||
Price-to-Tangible-Book | 0.54 | |||||
EV-to-EBIT | 0.06 | |||||
EV-to-EBITDA | 0.06 | |||||
EV-to-Revenue | -0.81 | |||||
EV-to-FCF | 0.17 | |||||
Price-to-GF-Value | 1.47 | |||||
| Price-to-Net-Current-Asset-Value | 0.81 | |||||
| Price-to-Net-Cash | 1.38 | |||||
Earnings Yield (Greenblatt) % | 1666.67 | |||||
FCF Yield % | -157.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SPRC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
SciSparc Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.856 | ||
| EPS (TTM) ($) | -3394.681 | ||
| Beta | 4.6785 | ||
| 3-Year Sharpe Ratio | -0.54 | ||
| 3-Year Sortino Ratio | -0.89 | ||
| Volatility % | 242.85 | ||
| 14-Day RSI | 36.15 | ||
| 14-Day ATR ($) | 0.924566 | ||
| 20-Day SMA ($) | 6.14625 | ||
| 12-1 Month Momentum % | -86.42 | ||
| 52-Week Range ($) | 2.98 - 80.1 | ||
| Shares Outstanding (Mil) | 0.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
SciSparc Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
SciSparc Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2025 | 2026-04-29 | 8.34 (+8.66%) | ||
| 0.111111:1 Stock Split | 2026-03-04 | 4.32 (-5.84%) | ||
| 0.047619:1 Stock Split | 2025-07-03 | 58.65 (-0.23%) | ||
| Annual report for 2024 | 2025-04-24 | 54.24 (+3.16%) | ||
| 0.0384615:1 Stock Split | 2023-09-28 | 1,019.16 (-16.37%) |
Show
Entries
SciSparc Ltd Frequently Asked Questions
What is SciSparc Ltd(SPRC)'s stock price today?
The current price of SPRC is $4.57. The 52 week high of SPRC is $80.10 and 52 week low is $2.98.
When is next earnings date of SciSparc Ltd(SPRC)?
The next earnings date of SciSparc Ltd(SPRC) is .
Does SciSparc Ltd(SPRC) pay dividends? If so, how much?
SciSparc Ltd(SPRC) does not pay dividend.
Guru Commentaries on NAS:SPRC
No articles.
Press Release
Articles on SciSparc Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers